Blog
New Drug Introduced
Posted:
The following announcement was issued by CollaGenex Pharmaceuticals: FIRST ORAL DRUG FOR ROSACEA COLLAGENEX PHARMACEUTICALS INTRODUCES ORACEA™ (doxycycline, USP) capsules 40 mg* * 30 mg immediate release and 10 mg delayed release beads
Read More
The following announcement was issued by CollaGenex Pharmaceuticals: FIRST ORAL DRUG FOR ROSACEA COLLAGENEX PHARMACEUTICALS INTRODUCES ORACEA™ (doxycycline, USP) capsules 40 mg* * 30 mg immediate release and 10 mg delayed release beads
Read More
Dry Eye Awareness
Posted:
The following announcement was issued by the National Women's Health Resource Center: Do You Live in a Dry Eye Hot Spot?
Read More
The following announcement was issued by the National Women's Health Resource Center: Do You Live in a Dry Eye Hot Spot?
Read More
Trail of Tears May Lead Scientists To First Diagnostic Test for Rosacea
Posted:
BARRINGTON, Illinois (June 14, 2006) -- A trail of tears may lead to the first diagnostic test for ocular rosacea, a common and potentially serious condition that may result in reduction of vision if left untreated.
Read More
BARRINGTON, Illinois (June 14, 2006) -- A trail of tears may lead to the first diagnostic test for ocular rosacea, a common and potentially serious condition that may result in reduction of vision if left untreated.
Read More
Survey Finds Facial Disorder Hurts More Than Appearance
Posted:
While the often-devastating impact of rosacea on facial appearance is well recognized, a new survey shows that physical discomfort is also experienced by the majority of people with this red-faced, acne-like disorder now estimated to affect more than 14 million Americans.
Read More
While the often-devastating impact of rosacea on facial appearance is well recognized, a new survey shows that physical discomfort is also experienced by the majority of people with this red-faced, acne-like disorder now estimated to affect more than 14 million Americans.
Read More
New Research Grants Awarded to Further Knowledge of Rosacea
Posted:
The National Rosacea Society (NRS) announced that five new studies have been awarded funding as part of its research grants program to advance scientific knowledge of the potential causes and other key aspects of this chronic and potentially devastating disorder that affects an estimated 14 million Americans.
Read More
The National Rosacea Society (NRS) announced that five new studies have been awarded funding as part of its research grants program to advance scientific knowledge of the potential causes and other key aspects of this chronic and potentially devastating disorder that affects an estimated 14 million Americans.
Read More